{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T18:43:34Z","timestamp":1763059414673,"version":"3.45.0"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>\n                    COVID-19 Vaccinations are associated with higher allergic reactions risk among adults. However, evidence on whether no vaccinated with COVID-19 vaccine is associated with fewer incidence among individuals with atopic diseases remains limited. This study is to investigate whether COVID-19 Vaccination is associated with increased risk of adult atopic diseases. A cross-sectional survey was conducted using data from the 2021 US National Health Interview Survey (NHIS) that included 29201 respondents aged 18 years or older adults. Multivariable logistic regression was conducted to estimate the association of COVID-19 vaccination and atopic disease. Crude and adjusted odds ratios (aORs) and 95% CIs were estimated. Analysis of the data was performed from October 01, 2023, to January 22, 2024. Of 29201 respondents (mean [SD] age, 52.6 [18.4] years; 13240 [45.3%] male), the US prevalence was 49.6% (unweighted, 95% CI, 49.1%\u221250.2%) from all years of the2021 NHIS for self-reported hay fever, 13.7% (unweighted,95% CI, 13.3%\u2212 14.1%) for asthma, 10.9% (unweighted, 95% CI,10.1%\u221211.3%) for skin allergy, 10.0% (unweighted,95% CI, 9.7%\u221210.4%) for food allergy, and 45.1% (unweighted,95% CI, 45.6%\u221245.7%) for no COVID-19 vaccination, 6.4% (95% CI, 6.1%\u22126.9%) for one COVID-19 vaccination, 43.1% (unweighted, 95% CI, 42.6%\u221243.7%) for two COVID-19 vaccinations, 5.3% (unweighted, 95% CI, 5.1%\u22125.6%) for more than 2 COVID-19 vaccinations. In multivariable analysis across the 2021 NHIS, COVID-19 vaccinations does not increase the risk of skin a\n                    <jats:italic>\n                      <jats:italic>llergy(aOR, 1.03;95%CI, 0.86\u20131.28; P\u2009=\u20090.135<\/jats:italic>\n                    <\/jats:italic>\n                    ), asthma (aOR, 1.05;95%CI,0.98\u20131.13; P\u2009=\u20090.164), and food allergy (aOR, 1.03;95%CI, 0.95\u20131.12; P\u2009=\u20090.437) in adults, compared with adults without COVID-19 vaccination; whereas, in patients with COVID-19 vaccination had significantly higher odds of hay fever (aOR, 1.21;95% CI, 1.15\u20131.27;P\u2009&lt;\u20090.001) compared with adults without COVID-19 vaccination. Further sensitivity and subgroup analysis suggested that the number of COVID-19 vaccinations was associated with newly diagnosed hay fever (aOR, 1.17 95% CI,1.10\u20131.24; P\u2009&lt;\u20090.001) and asthma (aOR, 1.12 95% CI,1.03\u20131.27; P\u2009=\u20090.011). In this cross-sectional study, COVID-19 vaccination was associated with higher risk incidence of hay fever, but COVID-19 vaccination was not associated with an increased in incidence risk in skin allergy, asthma and food allergy. The determinants of the association of COVID-19 vaccination with atopic diseases should be identified in the future studies are needed.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0336698","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T18:39:46Z","timestamp":1763059186000},"page":"e0336698","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between COVID-19 vaccination and atopic diseases in US adults: A retrospective cohort study"],"prefix":"10.1371","volume":"20","author":[{"given":"Min","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zixuan","family":"Bu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nana","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1491-5880","authenticated-orcid":true,"given":"Juebo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"issue":"9","key":"pone.0336698.ref001","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S1473-3099(22)00320-6","article-title":"Global impact of the first year of COVID-19 vaccination: a mathematical modelling study","volume":"22","author":"OJ Watson","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"pone.0336698.ref002","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1111\/all.14840","article-title":"Vaccines and allergic reactions: the past, the current COVID-19 pandemic, and future perspectives","volume":"76","author":"V Sampath","year":"2021","journal-title":"Allergy"},{"key":"pone.0336698.ref003","doi-asserted-by":"crossref","first-page":"46","DOI":"10.15585\/mmwr.mm7002e1","article-title":"Allergic reactions including anaphylaxis after receipt of the first dose of P\ufb01zer-BioNTech COVID-19 vaccine\u2014United States, 14\u201323 December 2020","volume":"70","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"pone.0336698.ref004","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1016\/j.jaip.2021.06.006","article-title":"The risk of allergic reaction to SARS-CoV-2 vaccines and recommended evaluation and management: a systematic review, meta-analysis, GRADE assessment, and international consensus approach","volume":"9","author":"M Greenhawt","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"9","key":"pone.0336698.ref005","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.25524","article-title":"Assessment of allergic and anaphylactic reactions to mRNA COVID-19 vaccines with confirmatory testing in a US regional health system","volume":"4","author":"CM Warren","year":"2021","journal-title":"JAMA Netw Open"},{"key":"pone.0336698.ref006","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2147\/TCRM.S98100","article-title":"Allergic diseases among children: nutritional prevention and intervention","volume":"12","author":"MA Hendaus","year":"2016","journal-title":"Ther Clin Risk Manag"},{"issue":"1","key":"pone.0336698.ref007","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jaci.2015.06.029","article-title":"Atopic dermatitis is associated with an increased risk for rheumatoid arthritis and inflammatory bowel disease, and a decreased risk for type 1 diabetes","volume":"137","author":"J Schmitt","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"pone.0336698.ref008","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/1203475416685078","article-title":"Atopic dermatitis, depression, and suicidality","volume":"21","author":"MN Nicholas","year":"2017","journal-title":"J Cutan Med Surg"},{"issue":"2","key":"pone.0336698.ref009","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jaci.2012.10.041","article-title":"Mental health comorbidity in patients with atopic dermatitis","volume":"131","author":"P Yaghmaie","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"pone.0336698.ref010","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/all.12685","article-title":"Association between adult atopic dermatitis, cardiovascular disease, and increased heart attacks in three population-based studies","volume":"70","author":"JI Silverberg","year":"2015","journal-title":"Allergy"},{"issue":"2","key":"pone.0336698.ref011","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11882-012-0330-z","article-title":"Impact of sleep as a specific marker of quality of life in allergic rhinitis","volume":"13","author":"V Gonz\u00e1lez-N\u00fa\u00f1ez","year":"2013","journal-title":"Curr Allergy Asthma Rep"},{"issue":"1","key":"pone.0336698.ref012","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/jid.2014.325","article-title":"Sleep disturbances in adults with eczema are associated with impaired overall health: a US population-based study","volume":"135","author":"JI Silverberg","year":"2015","journal-title":"J Invest Dermatol"},{"issue":"2","key":"pone.0336698.ref013","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.anai.2021.04.024","article-title":"Risk of allergic reaction in patients with atopic disease and recent coronavirus disease 2019 vaccination","volume":"127","author":"KN Dages","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"21","key":"pone.0336698.ref014","doi-asserted-by":"crossref","first-page":"14274","DOI":"10.3390\/ijerph192114274","article-title":"Incidence of asthma, atopic dermatitis, and allergic rhinitis in Korean adults before and during the COVID-19 pandemic using data from the Korea national health and nutrition examination survey","volume":"19","author":"HG Choi","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"pone.0336698.ref015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2014.12.013","article-title":"Association of atopic dermatitis with being overweight and obese: a systematic review and metaanalysis","volume":"72","author":"A Zhang","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"pone.0336698.ref016","article-title":"Risks for infection in patients with asthma (or other atopic conditions): is asthma more than a chronic airway disease?","volume":"134","author":"YJ Juhn","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"pone.0336698.ref017","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/MCP.0b013e328341005f","article-title":"Anxiety and depression in asthma","volume":"17","author":"F Di Marco","year":"2011","journal-title":"Curr Opin Pulm Med"},{"issue":"9","key":"pone.0336698.ref018","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003448","article-title":"Late-onset asthma predicts cardiovascular disease events: the wisconsin sleep cohort","volume":"5","author":"MC Tattersall","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"pone.0336698.ref019","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jaci.2012.10.041","article-title":"Mental health comorbidity in patients with atopic dermatitis","volume":"131","author":"P Yaghmaie","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"pone.0336698.ref020","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s40257-016-0209-1","article-title":"Complementary and alternative medicine for atopic dermatitis: an evidence-based review","volume":"17","author":"BL Vieira","year":"2016","journal-title":"Am J Clin Dermatol"},{"issue":"4","key":"pone.0336698.ref021","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s13671-022-00376-3","article-title":"The impact of immune-modifying treatments for skin diseases on the immune response to COVID-19 vaccines: a narrative review","volume":"11","author":"S-Y Liew","year":"2022","journal-title":"Curr Dermatol Rep"},{"issue":"6","key":"pone.0336698.ref022","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.17964","article-title":"Atopic dermatitis exacerbation after Covid-19 vaccination in Dupilumab-treated patients","volume":"36","author":"L Potestio","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10","key":"pone.0336698.ref023","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.3390\/vaccines10101616","article-title":"Allergic reactions to COVID-19 vaccination in high-risk allergic patients: the experience of Trieste university hospital (North-Eastern Italy)","volume":"10","author":"FL Filon","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"30","key":"pone.0336698.ref024","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000029571","article-title":"Incidence of immediate allergic reactions to mRNA COVID-19 vaccines in adults with drug allergies and other allergic disorders","volume":"101","author":"I Markovi\u0107","year":"2022","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"pone.0336698.ref025","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.anai.2021.04.024","article-title":"Risk of allergic reaction in patients with atopic disease and recent coronavirus disease 2019 vaccination","volume":"127","author":"KN Dages","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"15","key":"pone.0336698.ref026","article-title":"IL-13 is a driver of COVID-19 severity","volume":"6","author":"AN Donlan","year":"2021","journal-title":"JCI Insight"},{"issue":"23","key":"pone.0336698.ref027","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1093\/hmg\/ddt317","article-title":"A genome-wide association study of atopic dermatitis identifies loci with overlapping effects on asthma and psoriasis","volume":"22","author":"S Weidinger","year":"2013","journal-title":"Hum Mol Genet"},{"issue":"2","key":"pone.0336698.ref028","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jaci.2018.01.034","article-title":"Mast cells signal their importance in health and disease","volume":"142","author":"A Olivera","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"31","key":"pone.0336698.ref029","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1093\/eurheartj\/ehaa548","article-title":"Mast cell tryptase level should be checked in all patients with suspected Kounis syndrome","volume":"41","author":"S Khan","year":"2020","journal-title":"Eur Heart J"},{"issue":"12","key":"pone.0336698.ref030","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1111\/bcp.14112","article-title":"Immune-mediated adverse reactions to vaccines","volume":"85","author":"CA Jr Stone","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"pone.0336698.ref031","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1016\/j.jaip.2019.02.015","article-title":"Mastocytosis, quinolones, MRGPRX2, and anaphylaxis","volume":"7","author":"CR Weiler","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"pone.0336698.ref032","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.3389\/fimmu.2018.03027","article-title":"Mas-related G protein-coupled receptor-X2 (MRGPRX2) in drug hypersensitivity reactions","volume":"9","author":"G Porebski","year":"2018","journal-title":"Front Immunol"},{"issue":"6","key":"pone.0336698.ref033","doi-asserted-by":"crossref","first-page":"400","DOI":"10.18176\/jiaci.0562","article-title":"Delayed hypersensitivity reactions caused by drug excipients: a literature review","volume":"30","author":"ML Caballero","year":"2020","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"22","key":"pone.0336698.ref034","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.3390\/ijerph16224350","article-title":"Risk of cardiovascular mortality in relation to increased total serum IgE levels in older adults: a population-based cohort study","volume":"16","author":"K-B Min","year":"2019","journal-title":"Int J Environ Res Public Health"},{"issue":"5","key":"pone.0336698.ref035","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.aller.2013.03.005","article-title":"Position document: IgE-mediated allergy to egg protein","volume":"41","author":"A Martorell","year":"2013","journal-title":"Allergol Immunopathol (Madr)"},{"issue":"13","key":"pone.0336698.ref036","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/jama.2024.2071","article-title":"CDC Recommends additional COVID-19 booster for older adults","volume":"331","author":"S Anderer","year":"2024","journal-title":"JAMA"},{"issue":"7","key":"pone.0336698.ref037","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1001\/jama.2023.28340","article-title":"Missed vaccine doses tied to worse COVID-19 outcomes","volume":"331","author":"E Harris","year":"2024","journal-title":"JAMA"},{"issue":"5","key":"pone.0336698.ref038","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1080\/10937404.2022.2107591","article-title":"Principles of risk decision-making","volume":"25","author":"D Krewski","year":"2022","journal-title":"J Toxicol Environ Health B Crit Rev"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0336698","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T18:39:57Z","timestamp":1763059197000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0336698"}},"subtitle":[],"editor":[{"given":"Zuotao","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":38,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0336698","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]}}}